Results 301 to 310 of about 2,984,799 (310)
Some of the next articles are maybe not open access.
GMS Hygiene and Infection Control
Background: Antituberculosis drugs may cause mild, moderate or severe adverse drug reactions (ADR) leading to poor compliance. Description of the pattern of ADR and their related factors can help tuberculosis (TB) control program as part of the WHO ...
Motahareh Kheradmand+6 more
semanticscholar +1 more source
Background: Antituberculosis drugs may cause mild, moderate or severe adverse drug reactions (ADR) leading to poor compliance. Description of the pattern of ADR and their related factors can help tuberculosis (TB) control program as part of the WHO ...
Motahareh Kheradmand+6 more
semanticscholar +1 more source
Journal of Health Sciences and Professions Education
Introduction: SARS-COV-2 induced Corona Virus Disease 2019 (COVID-2019) is a current pandemic world is facing badly. To prevent infection and severe disease, there are various vaccine are developed.
Ankit Patel, Riddhi Bhatt, Bharat Gajjar
semanticscholar +1 more source
Introduction: SARS-COV-2 induced Corona Virus Disease 2019 (COVID-2019) is a current pandemic world is facing badly. To prevent infection and severe disease, there are various vaccine are developed.
Ankit Patel, Riddhi Bhatt, Bharat Gajjar
semanticscholar +1 more source
International Conference Intelligent Data Communication Technologies and Internet Things
Integrating Artificial Intelligence into Health Care involves employing AI technologies and Algorithms to reinforce various facets of Medical Domain including discovery of the drugs and its subsequent development.
Ch. Aneesh+4 more
semanticscholar +1 more source
Integrating Artificial Intelligence into Health Care involves employing AI technologies and Algorithms to reinforce various facets of Medical Domain including discovery of the drugs and its subsequent development.
Ch. Aneesh+4 more
semanticscholar +1 more source
Expert Opinion on Drug Safety
Background Interleukin-6 (IL-6) monoclonal antibodies are commonly acknowledged for their efficacy in managing coronavirus disease 2019 (COVID-19); however, there remains a paucity of comprehensive studies on their potential adverse effects.
Jing Hu+3 more
semanticscholar +1 more source
Background Interleukin-6 (IL-6) monoclonal antibodies are commonly acknowledged for their efficacy in managing coronavirus disease 2019 (COVID-19); however, there remains a paucity of comprehensive studies on their potential adverse effects.
Jing Hu+3 more
semanticscholar +1 more source
Ocular Toxoplasmosis: Therapy-Related Adverse Drug Reactions and Their Management
Klinische Monatsblätter für Augenheilkunde, 2017M. Helfenstein+5 more
semanticscholar +1 more source
[Analgesics in geriatric patients. Adverse side effects and interactions].
Zeitschrift für Gerontologie und Geriatrie (Print), 2015M. Gosch
semanticscholar +1 more source
Solute Carrier Transportome in Chemotherapy-Induced Adverse Drug Reactions.
Reviews of Physiology, Biochemistry and Pharmacology, 2020Jason T. Anderson+4 more
semanticscholar +1 more source
Side Effects and Toxicities of Targeted Therapies in Stage IV Melanoma
American Journal of Therapeutics, 2015P. Ascierto+7 more
semanticscholar +1 more source